chr17-16940415-G-T

Variant summary

Our verdict is Uncertain significance. The variant received 2 ACMG points: 8P and 6B. PP5_Very_StrongBP4BS1_SupportingBS2

The NM_012452.3(TNFRSF13B):​c.542C>A​(p.Ala181Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00539 in 1,614,040 control chromosomes in the GnomAD database, including 49 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A181V) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0049 ( 5 hom., cov: 32)
Exomes 𝑓: 0.0054 ( 44 hom. )

Consequence

TNFRSF13B
NM_012452.3 missense

Scores

2
4
11

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:30U:1O:1

Conservation

PhyloP100: 0.00700

Publications

85 publications found
Variant links:
Genes affected
TNFRSF13B (HGNC:18153): (TNF receptor superfamily member 13B) The protein encoded by this gene is a lymphocyte-specific member of the tumor necrosis factor (TNF) receptor superfamily. It interacts with calcium-modulator and cyclophilin ligand (CAML). The protein induces activation of the transcription factors NFAT, AP1, and NF-kappa-B and plays a crucial role in humoral immunity by interacting with a TNF ligand. This gene is located within the Smith-Magenis syndrome region on chromosome 17. [provided by RefSeq, Jul 2008]
TNFRSF13B Gene-Disease associations (from GenCC):
  • immunodeficiency, common variable, 2
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Laboratory for Molecular Medicine, G2P, ClinGen
  • common variable immunodeficiency
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 2 ACMG points.

PP5
Variant 17-16940415-G-T is Pathogenic according to our data. Variant chr17-16940415-G-T is described in ClinVar as Pathogenic/Likely_pathogenic. ClinVar VariationId is 5303.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP4
Computational evidence support a benign effect (MetaRNN=0.08364344). . Strength limited to SUPPORTING due to the PP5.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00486 (740/152274) while in subpopulation NFE AF = 0.006 (408/68008). AF 95% confidence interval is 0.00552. There are 5 homozygotes in GnomAd4. There are 427 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAd4 at 5 AD,AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_012452.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TNFRSF13B
NM_012452.3
MANE Select
c.542C>Ap.Ala181Glu
missense
Exon 4 of 5NP_036584.1O14836-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TNFRSF13B
ENST00000261652.7
TSL:1 MANE Select
c.542C>Ap.Ala181Glu
missense
Exon 4 of 5ENSP00000261652.2O14836-1
TNFRSF13B
ENST00000583789.1
TSL:1
c.404C>Ap.Ala135Glu
missense
Exon 3 of 4ENSP00000462952.1O14836-2
TNFRSF13B
ENST00000579315.5
TSL:3
c.446-7239C>A
intron
N/AENSP00000464069.1J3QR67

Frequencies

GnomAD3 genomes
AF:
0.00486
AC:
740
AN:
152156
Hom.:
5
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000796
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00190
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000385
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0250
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00600
Gnomad OTH
AF:
0.00144
GnomAD2 exomes
AF:
0.00533
AC:
1336
AN:
250718
AF XY:
0.00526
show subpopulations
Gnomad AFR exome
AF:
0.000800
Gnomad AMR exome
AF:
0.000868
Gnomad ASJ exome
AF:
0.0000995
Gnomad EAS exome
AF:
0.000272
Gnomad FIN exome
AF:
0.0243
Gnomad NFE exome
AF:
0.00650
Gnomad OTH exome
AF:
0.00441
GnomAD4 exome
AF:
0.00544
AC:
7954
AN:
1461766
Hom.:
44
Cov.:
31
AF XY:
0.00532
AC XY:
3867
AN XY:
727176
show subpopulations
African (AFR)
AF:
0.000777
AC:
26
AN:
33478
American (AMR)
AF:
0.000939
AC:
42
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.000191
AC:
5
AN:
26136
East Asian (EAS)
AF:
0.000126
AC:
5
AN:
39700
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86256
European-Finnish (FIN)
AF:
0.0254
AC:
1355
AN:
53340
Middle Eastern (MID)
AF:
0.000349
AC:
2
AN:
5736
European-Non Finnish (NFE)
AF:
0.00567
AC:
6310
AN:
1112010
Other (OTH)
AF:
0.00344
AC:
208
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
499
999
1498
1998
2497
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
228
456
684
912
1140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00486
AC:
740
AN:
152274
Hom.:
5
Cov.:
32
AF XY:
0.00574
AC XY:
427
AN XY:
74454
show subpopulations
African (AFR)
AF:
0.000794
AC:
33
AN:
41568
American (AMR)
AF:
0.00190
AC:
29
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.000386
AC:
2
AN:
5182
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4812
European-Finnish (FIN)
AF:
0.0250
AC:
265
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00600
AC:
408
AN:
68008
Other (OTH)
AF:
0.00142
AC:
3
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
35
70
106
141
176
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00355
Hom.:
2
Bravo
AF:
0.00321
TwinsUK
AF:
0.00728
AC:
27
ALSPAC
AF:
0.00545
AC:
21
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.00605
AC:
52
ExAC
AF:
0.00534
AC:
648
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00447
EpiControl
AF:
0.00528

ClinVar

ClinVar submissions
Significance:Pathogenic/Likely pathogenic
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
12
1
-
not provided (13)
11
-
-
Immunodeficiency, common variable, 2 (13)
3
-
-
Immunoglobulin A deficiency 2 (3)
1
-
-
Common variable immunodeficiency (1)
1
-
-
Immunoglobulin A deficiency 2;C3150354:Immunodeficiency, common variable, 2 (1)
1
-
-
See cases (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.74
BayesDel_addAF
Benign
-0.056
T
BayesDel_noAF
Pathogenic
0.15
CADD
Benign
12
DANN
Benign
0.80
DEOGEN2
Uncertain
0.63
D
Eigen
Benign
-0.30
Eigen_PC
Benign
-0.48
FATHMM_MKL
Benign
0.044
N
LIST_S2
Benign
0.68
T
MetaRNN
Benign
0.084
T
MetaSVM
Uncertain
0.31
D
MutationAssessor
Benign
2.0
M
PhyloP100
0.0070
PrimateAI
Benign
0.35
T
PROVEAN
Uncertain
-3.3
D
REVEL
Uncertain
0.61
Sift
Benign
0.069
T
Sift4G
Benign
0.23
T
Polyphen
0.89
P
Vest4
0.47
MVP
0.87
MPC
0.069
ClinPred
0.057
T
GERP RS
2.4
Varity_R
0.18
gMVP
0.46
Mutation Taster
=90/10
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs72553883; hg19: chr17-16843729; COSMIC: COSV108022594; COSMIC: COSV108022594; API